Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti- intercellullar adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506

Transplantation

Volumn 62, Issue 1, 1996, Pages 117-122

  Bashuda, Hisashi ^a   Takazawa, Kenji ^a   Tamatani, Takuya ^b   Miyasaka, Masayuki ^c   Yagita, Hideo ^a   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Pharmaceutical Basic Res Labs   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LEUKOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TRANSFUSION; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD TRANSFUSION; CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; RATS; RATS, INBRED F344; RATS, INBRED LEW; T-LYMPHOCYTES, CYTOTOXIC; TACROLIMUS;

EID: 0030005599     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00022     Document Type: Article

References (34)

1. Mason D, Morris P. Effector mechanism in allograft rejection. Annu Rev Immunol 1986; 4: 119.
2. Mueller D, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445.
3. Jones LA, Chin LT, Merriam GR, et al. Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J Exp Med 1990; 172: 1277.
4. Sperling Al, Green JM, Mosley RL, et al. CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J Exp Med 1995; 182: 139.
5. van Seventer GA, Shimizu Y, Horgan KJ, et al. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144: 4579.
6. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1991; 339: 61.
7. Fougerolles ARD, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function- associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175: 185.
8. + T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med 1990; 172: 1185.
9. Koulova L, Clark EA, Shu G, et al. The CD28 ligand B7/BB1 provides costimulatory signal for activation of CD4+T cells. J Exp Med 1991; 173: 759.
10. Azuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76.
11. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that cstimulates human T cell proliferation. Science 1993; 262: 909.
12. Isobe M, Yagita H, Okumura K, et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
13. Tamatani T, Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 1990; 2: 165.
14. Tamatani T, Kotani M, Miyasaka M. Characterization of the rat leukocyte intergrin, CD11/CD18, by the use of LFA-1 subunit- specific monoclonal antibodies. Eur J Immunol 1991; 21: 627.
15. Altman PL, Dorothy DK. Inbred and genetically defined strains of laboratory animals. Part 1: Mouse and rat. Bethesda, MD: Federation of American Societies for Experimental Biology, 1979: 306.
16. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 225: 57.
17. Billingham RE, Medawar PB. The technique of free skin grafting in mammals. J Exp Med 1951; 28: 385.
18. Fujiwara H, Hamaoka T, Shearer GM, et al. The augmentation of in vitro and in vivo tumor specific T cell-mediated immunity by amplifier T lymphocytes. J Immunol 1980; 124: 863.
19. DeSilva DR, Urdahl KB, Jenkins MK. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 1991; 147: 3261.
20. Chen Z, Cobbold S, Metcalfe S, et al. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992; 22: 805.
21. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
22. Isobe M, Suzuki J, Yagita H, et al. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. J Immunol 1994; 153: 5810.
23. Jendrisak M, Jendrisak G, Mohanakumar T. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. Transplant Proc 1993; 25: 825.
24. Fabrega AJ, Blanchard JM, Rivas PA, Pollak R. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. Transplantation 1993; 56: 1579.
25. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608.
26. Brunson ME, Tchervenkov JI, Alexander JW. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Transplantation 1991; 52: 545.
27. Williams GM, Hume DM, Hudson RP, Morris PJ, Kano K, Milgron F. "Hyperacute" renal-homograft rejection in man. N Engl J Med 1968; 279: 611.
28. Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 1992; 257: 1134.
29. Miyagawa S, Stepkowski SW, Kahan BD. Mechanism of unresponsiveness in rats induced by a short course of FK506 or CyA. Transplant Proc 1991; 23: 334.
30. Iwata H, Kitagawa S, Sato S, et al. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. Transplantation 1993; 56: 173.
31. + suppressor cells inhibit the function of effector cells of experimental autoimmune enceph- alomyelitis through a mechanism involving transforming growth factor-b. J Immunol 1991; 146: 1163.
32. Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor b by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037.
33. Miller A, Lider O, Roberts AB, et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci USA 1992; 89: 421.
34. Ding L, Linsley PS, Huang LY, et al. IL-10 inhibits macrophage costimulation activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224.